Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kort-SGS trial of intralesional Kenacort after endoscopic treatment for subglottic stenosis
2018-000614-37Phase 2Completed
- Sponsor
- Region Örebro län
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triamcinolone acetonide in subglottic stenosis (SGS) (2 arms), sponsored by Region Örebro län. Primary endpoint: Months asymptomatic from stenosis. Started Apr 2018; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
subglottic stenosis (SGS)
Beyond the preview
Go deeper on 2018-000614-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000614-37.